Multiple sclerosis is a debilitating disease of the central nervous system, often leading to disability The immune system attacks the body and destroys the myelin that protects and insulates nerve fibers. Myelin increases the speed at which electrical impulses travel between the brain and the rest of the body and is essential for the proper functioning of the nervous system. Loss of myelin causes disrupted signals between the brain and the body.

Multiple sclerosis treatments include corticosteroids to reduce nerve inflammation and plasma exchange, control symptoms and slow disease progression. The so-called modifying drugs in the form of injections and pills are not effective and have side effects. In the case of an autoimmune disorder, the immune system, which is there to protect the body, is confused and perceives the body’s own tissues as antigens and starts attacking and destroying them.

Cannabinoids as the forces of homeostasis and health fight back against the mutated ally, the immune system. In that sense, CBD can slow the neurodegenerative process of multiple sclerosis, which leads to disability, as the CB2 receptors in the areas of the spine that are affected by multiple sclerosis are increased. Studies have shown that cannabinoids are involved in the regulation of the immune system through action on cannabinoid receptors of the endocannabinoid system. Cannabinoids are potent anti-inflammatory agents with neuroregenerative properties. Cannabinoids have neuroprotective effects in multiple sclerosis and reduce myelin damage caused by inflammation. Cannabinoids administered in patients with multiple sclerosis reduce neurological disability, improve motor coordination and slow disease progression. Moreover, CBD can help MS patients control the symptoms associated with the disease. CBD has been shown to be effective in reducing pain, muscle stiffness and spasms in MS patients.